| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2019 | Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis. | Gao, X; Yang, HI ; Trinh, H; Jeong, D; Li, J; Zhang, J; Le, A; Hoang, J; Nguyen, P; Henry, L; Nguyen, MH | European Journal of Gastroenterology & Hepatology Volume Publish Ahead of Print | | | |
| 2019 | Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. | Yeo, YH; Ho, HJ; Yang, HI ; Tseng, TC; Hosaka, T; Trinh, HN; Kwak, MS; Park, YM; Fung, JYY; Buti, M; Rodriguez, M; Treeprasertsuk, S; Preda, CM; Ungtrakul, T; Charatcharoenwitthaya, P; Li, X; Li, J; Zhang, J; Le, MH; Wei, B; Zou, B; Le, A; Jeong, D; Chien, N; Kam, L; Lee, CC; Riveiro-Barciela, M; Istratescu, D; Sriprayoon, T; Chong, Y; Tanwandee, T; Kobayashi, M; Suzuki, F; Yuen, MF; Lee, HS; Kao, JH; Lok, AS; Wu, CY; Nguyen, MH | Gastroenterology 156(3), 635-646.e9 | | | |
| 2016 | Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. | Hoang, JK; Yang, HI ; Le, A; Nguyen, NH; Lin, D; Vu, VD; Chaung, K; Nguyen, V; Trinh, HN; Li, J; Zhang, JQ; Chen, CJ ; Nguyen, MH | Medicine 95(31), e4433 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2019 | Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study | Nguyen, MH; Yang, HI ; Le, A; Henry, L; Nguyen, N; Lee, MH; Zhang, J; Wong, C; Wong, C; Trinh, H | The Journal of infectious diseases 219(1), 10-18 | | | |
| 2016 | Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. | Yang, HI ; Nguyen, N; Hoang, J; Kim, Y; Vu, V; Le, A; Chaung, K; Nguyen, V; Trinh, H; Li, J; Zhang, J; Hsing, A; Chen, CJ ; Nguyen, MH | Alimentary pharmacology & therapeutics 44(8), 846-855 | | | |
